Neptune Technologies & Bioressources Inc.(TSX VENTURE: NTB)

Editors Note: There is a photo associated with this press release.

On October 25, 2010 The Howard Group hosted its 2nd "Opportunity Knocks" investor conference in Calgary. Dr. Tina Sampalis, Chief Scientific Officer of Neptune provided an overview of the company to an audience of investment advisors & private investors.

A recording of the presentation is now available online. Click here to view - http://www.howardgroupinc.com/conference2010.html

Highlights on Neptune are as follows:


--  First half F2011 revenues rose 95% to over $8 million versus F2010 first
    half.
--  Earnings and EBITDA positive.
--  Key announcements on animal studies supporting extreme effectiveness on
    cholesterol related issues.
--  Expect pending approval from health regulatory bodies that will
    facilitate Phase II clinical studies
--  Bayer expected to launch major roll-out of Arctic Wonder (Neptune)
    dietary supplement in Q1/2011.

About Neptune Technologies & Bioressources Inc.

Neptune is an industry-recognized leader in the innovation, production and formulation of science-based and clinically proven novel phospholipid products for the nutraceutical and pharmaceutical markets. The Company focuses on growing consumer health markets including cardiovascular, inflammatory and neurological diseases driven by consumers taking a more proactive approach to managing health and preventing disease. The Company sponsors clinical trials aimed to demonstrate its product health benefits and to obtain regulatory approval for label health claims. Neptune is continuously expanding its intellectual property portfolio as well as clinical studies and regulatory approvals. Neptune's products are marketed and distributed in over 20 countries worldwide.

To view the photo associated with this release, please visit the following link: http://www.marketwire.com/library/20101109-1109tina_800.jpg

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contacts: Neptune Tech & Bioressources Andre Godin VP Administration & Finance (450) 687-2262 (450) 687-2272 (FAX) a.godin@neptunebiotech.com www.neptunebiotech.com The Howard Group Inc. Bob Beaty Investor Relations (403) 221-0915 or Toll free: (888) 221-0915 info@howardgroupinc.com www.howardgroupinc.com

New Tymbal Resources (TSXV:NTB)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more New Tymbal Resources Charts.
New Tymbal Resources (TSXV:NTB)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more New Tymbal Resources Charts.